Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

GeneDx Holdings (WGS) Income from Continuing Operations: 2020-2025

Historic Income from Continuing Operations for GeneDx Holdings (WGS) over the last 6 years, with Sep 2025 value amounting to -$7.6 million.

  • GeneDx Holdings' Income from Continuing Operations rose 8.14% to -$7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 102.50%. This contributed to the annual value of -$52.3 million for FY2024, which is 70.25% up from last year.
  • As of Q3 2025, GeneDx Holdings' Income from Continuing Operations stood at -$7.6 million, which was down 170.64% from $10.8 million recorded in Q2 2025.
  • GeneDx Holdings' 5-year Income from Continuing Operations high stood at $32.7 million for Q3 2021, and its period low was -$308.7 million during Q4 2022.
  • Moreover, its 3-year median value for Income from Continuing Operations was -$20.2 million (2024), whereas its average is -$21.0 million.
  • As far as peak fluctuations go, GeneDx Holdings' Income from Continuing Operations skyrocketed by 157.81% in 2021, and later plummeted by 668.23% in 2022.
  • Quarterly analysis of 5 years shows GeneDx Holdings' Income from Continuing Operations stood at -$40.2 million in 2021, then tumbled by 668.23% to -$308.7 million in 2022, then skyrocketed by 91.65% to -$25.8 million in 2023, then soared by 121.10% to $5.4 million in 2024, then climbed by 8.14% to -$7.6 million in 2025.
  • Its last three reported values are -$7.6 million in Q3 2025, $10.8 million for Q2 2025, and -$6.5 million during Q1 2025.